|
Volumn 51, Issue 11, 2010, Pages 681-683
|
PIVKA-II is a predictive marker in the treatment response of sorafenib to hepatocellular carcinoma
|
Author keywords
[No Author keywords available]
|
Indexed keywords
DECARBOXYPROTHROMBIN;
SORAFENIB;
ADVANCED CANCER;
ARTICLE;
CLINICAL ARTICLE;
CLINICAL ASSESSMENT;
DIAGNOSTIC TEST ACCURACY STUDY;
DIAGNOSTIC VALUE;
HUMAN;
HYPOXEMIA;
LIVER CELL CARCINOMA;
PREDICTIVE VALIDITY;
PROTEIN BLOOD LEVEL;
TREATMENT RESPONSE;
|
EID: 78650460651
PISSN: 04514203
EISSN: None
Source Type: Journal
DOI: 10.2957/kanzo.51.681 Document Type: Article |
Times cited : (3)
|
References (3)
|